Our first main finding was that αSyn SAA positivity was associated with elevated Aβ-related CSF p-tau181 levels, suggesting enhanced tau hyperphosphorylation and secretion of p-tau in response to Aβ in AD patients with evidence of Lewy-body co-pathology. Here, MAPT is linked to Alzheimer disease.